Crescendo Biologics to participate in upcoming investor conferences
Press Releases
10 October 2022
Crescendo Biologics’ CEO shortlisted for ‘Private Company CEO of the Year’ at the 2022 European Lifestars Awards
13 September 2022
Crescendo Biologics shortlisted for ‘Most Impactful UK Deal’ at 2022 OBN Awards
06 July 2022
Crescendo Biologics announces nomination of second proprietary clinical candidate from immuno-oncology Humabody VH development portfolio
14 June 2022
Crescendo Biologics to participate in upcoming investor conferences
04 May 2022
Crescendo Biologics to participate in upcoming conferences
09 March 2022
Crescendo Biologics announces presentations at AACR 2022
03 February 2022
Crescendo Biologics to participate in upcoming investor conferences
10 January 2022
BioNTech and Crescendo Biologics announce global collaboration to develop multi-specific precision immunotherapies